Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 171

1.

Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients.

Wimmers F, de Haas N, Scholzen A, Schreibelt G, Simonetti E, Eleveld MJ, Brouwers HM, Beldhuis-Valkis M, Joosten I, de Jonge MI, Gerritsen WR, de Vries IJ, Diavatopoulos DA, Jacobs JF.

Sci Rep. 2017 Mar 7;7:43486. doi: 10.1038/srep43486.

2.

Changes in peripheral immune cell numbers and functions in octogenarian walkers - an acute exercise study.

van der Geest KSM, Wang Q, Eijsvogels TMH, Koenen HJP, Joosten I, Brouwer E, Hopman MTE, Jacobs JFM, Boots AMH.

Immun Ageing. 2017 Feb 22;14:5. doi: 10.1186/s12979-017-0087-2. eCollection 2017.

3.

Single CD28 stimulation induces stable and polyclonal expansion of human regulatory T cells.

He X, Smeets RL, van Rijssen E, Boots AM, Joosten I, Koenen HJ.

Sci Rep. 2017 Feb 22;7:43003. doi: 10.1038/srep43003.

4.

Embracing Complexity beyond Systems Medicine: A New Approach to Chronic Immune Disorders.

Te Velde AA, Bezema T, van Kampen AH, Kraneveld AD, 't Hart BA, van Middendorp H, Hack EC, van Montfrans JM, Belzer C, Jans-Beken L, Pieters RH, Knipping K, Huber M, Boots AM, Garssen J, Radstake TR, Evers AW, Prakken BJ, Joosten I.

Front Immunol. 2016 Dec 12;7:587. doi: 10.3389/fimmu.2016.00587. eCollection 2016.

5.

Differential Effects of Environmental and Genetic Factors on T and B Cell Immune Traits.

Aguirre-Gamboa R, Joosten I, Urbano PC, van der Molen RG, van Rijssen E, van Cranenbroek B, Oosting M, Smeekens S, Jaeger M, Zorro M, Withoff S, van Herwaarden AE, Sweep FC, Netea RT, Swertz MA, Franke L, Xavier RJ, Joosten LA, Netea MG, Wijmenga C, Kumar V, Li Y, Koenen HJ.

Cell Rep. 2016 Nov 22;17(9):2474-2487. doi: 10.1016/j.celrep.2016.10.053. Epub 2016 Nov 3.

6.

Host and Environmental Factors Influencing Individual Human Cytokine Responses.

Ter Horst R, Jaeger M, Smeekens SP, Oosting M, Swertz MA, Li Y, Kumar V, Diavatopoulos DA, Jansen AF, Lemmers H, Toenhake-Dijkstra H, van Herwaarden AE, Janssen M, van der Molen RG, Joosten I, Sweep FC, Smit JW, Netea-Maier RT, Koenders MM, Xavier RJ, van der Meer JW, Dinarello CA, Pavelka N, Wijmenga C, Notebaart RA, Joosten LA, Netea MG.

Cell. 2016 Nov 3;167(4):1111-1124.e13. doi: 10.1016/j.cell.2016.10.018.

PMID:
27814508
7.

Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies.

Lord P, Spiering R, Aguillon JC, Anderson AE, Appel S, Benitez-Ribas D, Ten Brinke A, Broere F, Cools N, Cuturi MC, Diboll J, Geissler EK, Giannoukakis N, Gregori S, van Ham SM, Lattimer S, Marshall L, Harry RA, Hutchinson JA, Isaacs JD, Joosten I, van Kooten C, Lopez Diaz de Cerio A, Nikolic T, Oral HB, Sofronic-Milosavljevic L, Ritter T, Riquelme P, Thomson AW, Trucco M, Vives-Pi M, Martinez-Caceres EM, Hilkens CM.

PeerJ. 2016 Aug 30;4:e2300. doi: 10.7717/peerj.2300. eCollection 2016.

8.

Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis.

van den Reek JMPA, Coenen MJH, van de L'Isle Arias M, Zweegers J, Rodijk-Olthuis D, Schalkwijk J, Vermeulen SH, Joosten I, van de Kerkhof PCM, Seyger MMB, Zeeuwen PLJM, de Jong EMGJ.

Br J Dermatol. 2017 May;176(5):1288-1296. doi: 10.1111/bjd.15005. Epub 2017 Apr 10.

PMID:
27564082
9.

How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies?

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar M, Bots ML, Drop AC, Plaisier L, Seelen MA, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MG, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MH, van Ittersum FJ, Nurmohamed A, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJ, Bemelman FJ, Hoitsma A, van der Boog PJ, de Fijter JW, Betjes MG, Heidt S, Roelen DL, Claas FH, Otten HG.

HLA. 2016 Sep;88(3):110-9. doi: 10.1111/tan.12860. Epub 2016 Aug 18.

PMID:
27534609
10.

Understanding human immune function using the resources from the Human Functional Genomics Project.

Netea MG, Joosten LA, Li Y, Kumar V, Oosting M, Smeekens S, Jaeger M, Ter Horst R, Schirmer M, Vlamakis H, Notebaart R, Pavelka N, Aguirre-Gamboa RR, Swertz MA, Tunjungputri RN, van de Heijden W, Franzosa EA, Ng A, Graham D, Lassen K, Schraa K, Netea-Maier R, Smit J, de Mast Q, van de Veerdonk F, Kullberg BJ, Tack C, van de Munckhof I, Rutten J, van der Graaf J, Franke L, Hofker M, Jonkers I, Platteel M, Maatman A, Fu J, Zhernakova A, van der Meer JW, Dinarello CA, van der Ven A, Huttenhouwer C, Koenen H, Joosten I, Xavier RJ, Wijmenga C.

Nat Med. 2016 Aug 4;22(8):831-3. doi: 10.1038/nm.4140. No abstract available.

PMID:
27490433
11.

Cell Surface Expression of HLA-Cw6 by Human Epidermal Keratinocytes: Positive Regulation by Cytokines, Lack of Correlation to a Variant Upstream of HLA-C.

van den Bogaard EH, Tijssen HJ, Rodijk-Olthuis D, van Houwelingen KP, Coenen MJ, Marget M, Schalkwijk J, Joosten I.

J Invest Dermatol. 2016 Sep;136(9):1903-6. doi: 10.1016/j.jid.2016.05.112. Epub 2016 Jun 11. No abstract available.

PMID:
27297019
12.

A TNFR2-Agonist Facilitates High Purity Expansion of Human Low Purity Treg Cells.

He X, Landman S, Bauland SC, van den Dolder J, Koenen HJ, Joosten I.

PLoS One. 2016 May 25;11(5):e0156311. doi: 10.1371/journal.pone.0156311. eCollection 2016.

13.

Inflammation-associated changes in lipid composition and the organization of the erythrocyte membrane.

Dinkla S, van Eijk LT, Fuchs B, Schiller J, Joosten I, Brock R, Pickkers P, Bosman GJ.

BBA Clin. 2016 Apr 3;5:186-92. doi: 10.1016/j.bbacli.2016.03.007. eCollection 2016 Jun.

14.

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture.

He X, de Oliveira VL, Keijsers R, Joosten I, Koenen HJ.

J Vis Exp. 2016 Apr 8;(110):e52564. doi: 10.3791/52564.

PMID:
27166763
15.

Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation.

Michelo CM, Fasse E, van Cranenbroek B, Linda K, van der Meer A, Abdelrazik H, Joosten I.

Transpl Immunol. 2016 Jul;37:1-9. doi: 10.1016/j.trim.2016.04.008. Epub 2016 Apr 30.

16.

Platelet microparticles inhibit IL-17 production by regulatory T cells through P-selectin.

Dinkla S, van Cranenbroek B, van der Heijden WA, He X, Wallbrecher R, Dumitriu IE, van der Ven AJ, Bosman GJ, Koenen HJ, Joosten I.

Blood. 2016 Apr 21;127(16):1976-86. doi: 10.1182/blood-2015-04-640300. Epub 2016 Feb 22.

17.

High mobility group box 1 is increased in the sera of psoriatic patients with disease progression.

Bergmann C, Strohbuecker L, Lotfi R, Sucker A, Joosten I, Koenen H, K├Ârber A.

J Eur Acad Dermatol Venereol. 2016 Mar;30(3):435-41. doi: 10.1111/jdv.13564. Epub 2016 Feb 2.

PMID:
26834049
18.

Investigation of crimson-dyed fibres for a new approach on the characterization of cochineal and kermes dyes in historical textiles.

Serrano A, van den Doel A, van Bommel M, Hallett J, Joosten I, van den Berg KJ.

Anal Chim Acta. 2015 Oct 15;897:116-27. doi: 10.1016/j.aca.2015.09.046. Epub 2015 Oct 3.

PMID:
26515013
19.

The role of interleukin-1 beta in the pathophysiology of Schnitzler's syndrome.

de Koning HD, Schalkwijk J, Stoffels M, Jongekrijg J, Jacobs JF, Verwiel E, Koenen HJ, Preijers F, Holzinger D, Joosten I, van der Meer JW, Simon A.

Arthritis Res Ther. 2015 Jul 22;17:187. doi: 10.1186/s13075-015-0696-0.

20.

Quantitative measurement of immunoglobulins and free light chains using mass spectrometry.

VanDuijn MM, Jacobs JF, Wevers RA, Engelke UF, Joosten I, Luider TM.

Anal Chem. 2015 Aug 18;87(16):8268-74. doi: 10.1021/acs.analchem.5b01263. Epub 2015 Jul 28.

PMID:
26168337

Supplemental Content

Loading ...
Support Center